carboxyethylphosphoramide mustard

Known as: CEPM cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2017
012319992017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The dose-limiting toxic effect of cyclophosphamide (CY) is cardiotoxicity. The pathogenesis of myocardial damage is poorly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
This study describes for the first time a method for the sequential analysis of the enantiomers of cyclophosphamide (CY) and its… (More)
  • figure 2
  • table 2
  • figure 3
  • table 3
  • table 4
Is this relevant?
2009
2009
A rapid and selective method for simultaneous determination of cyclophosphamide and its metabolite carboxyethylphosphoramide… (More)
Is this relevant?
2009
2009
This study investigates the efficacy and safety of personalized cyclophosphamide (CY) dosing in 50 patients receiving CY along… (More)
Is this relevant?
2009
2009
Cyclophosphamide-based regimens are front-line treatment for numerous pediatric malignancies; however, current dosing methods… (More)
  • table 2
  • table 3
  • table 4
  • table 5
  • figure 1
Is this relevant?
2006
2006
PURPOSE Dose-related toxicity of cyclophosphamide may be reduced and therapeutic efficacy may be improved by pharmacokinetic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2006
2006
A method is described for the quantification of two metabolites of cyclophosphamide, specifically 4-hydroxycyclophosphamide (HCy… (More)
Is this relevant?
2006
2006
Although limited data are available about cyclophosphamide disposition in patients with renal insufficiency, nothing has been… (More)
Is this relevant?
1999
1999
It has been reported that the toxicity of carmustine (BCNU) cyclophosphamide (CY)/etoposide regimen (when BCNU is split into 4… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?